Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -4.91 | N/A |
PEG Ratio (TTM) | 1.67 | N/A |
P/S Ratio (TTM) | 1.51 | N/A |
P/B Ratio (TTM) | 4.31 | N/A |
P/FCF Ratio (TTM) | -16.54 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -35.68% | N/A |
ROE (TTM) | -75.89% | N/A |
Net Profit Margin (TTM) | -19.31% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -14.70% | -38.19% | N/A |
Revenue | 0.69% | 25.27% | N/A |
Net Income | -18.67% | -6.74% | N/A |
Cash Flow | -0.49% | -145.50% | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.18 | N/A |
Quick Ratio (TTM) | 2.18 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |